Sangamo Therapeutics Inc
(NAS:SGMO)
$
2.3
0.16 (7.48%)
Market Cap: 479.89 Mil
Enterprise Value: 468.41 Mil
PE Ratio: 0
PB Ratio: 12.23
GF Score: 47/100 Sangamo Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2021 / 03:00PM GMT
Release Date Price:
$10.89
(+1.11%)
Maury Raycroft
(Trades, Portfolio) LLC - Analyst
Hi, everyone. My name is Maury Raycroft and I'm one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome Sandy Macrae, the CEO of Sangamo. Thanks for joining us today, Sandy.
Sandy Macrae
Sangamo Therapeutics, Inc. - CEO
Good morning. It's a pleasure to be with you.
Maury Raycroft
(Trades, Portfolio) LLC - Analyst
And this is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot